The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMajedie Inv. Regulatory News (MAJE)

Share Price Information for Majedie Inv. (MAJE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 248.00
Bid: 242.00
Ask: 248.00
Change: 1.00 (0.41%)
Spread: 6.00 (2.479%)
Open: 248.00
High: 248.00
Low: 248.00
Prev. Close: 244.00
MAJE Live PriceLast checked at -
Majedie is an Investment Trust

To maximise total shareholder return whilst increasing dividends by more than the rate of inflation over the long-term by investing in securities of publicly quoted companies worldwide, though it may invest in unquoted securities.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notice of General Meeting

20 Dec 2022 07:00

RNS Number : 2372K
Majedie Investments PLC
20 December 2022
 

Majedie Investments PLC

Publication of a Circular and Notice of a General Meeting

 

Majedie Investments plc (the "Company") has today published a circular (the "Circular") including notice of a general meeting (the " General Meeting"), to be held at City of London Club, 19 Old Broad Street, London EC2N 1DS on 25 January 2023 at 11.45 a.m., at which Shareholders will be asked to approve the New Investment Objective and Policy.

Background

On 10 November 2022, the Board announced that, following an extensive review of the Company's investment management arrangements, the Company had entered into a conditional agreement to appoint Marylebone Partners LLP ("Marylebone Partners") as the Company's investment manager. The Board further announced that, in connection with the proposed appointment of Marylebone Partners and subject to Shareholder approval, the Board was proposing to amend the Company's investment objective and policy to follow a liquid endowment investment strategy.

The purpose of the Circular is to set out further detail on the New Investment Objective and Policy and the proposed appointment of Marylebone Partners (the "Proposals"), and to convene a general meeting of the Company (the "General Meeting").

The Proposals

A resolution will be proposed at the General Meeting to approve the New Investment Objective and Policy (the "Resolution").

The appointment of Marylebone Partners as the Company's investment manager is conditional upon Shareholders voting in favour of the Resolution to adopt the New Investment Objective and Policy at the General Meeting.

The Board considers that the Proposals and the Resolution to be proposed at the General Meeting are in the best interests of the Company and its Shareholders as a whole. Accordingly, the Board unanimously recommends that Shareholders vote in favour of the Resolution.

Expected Timetable

Latest time and date for receipt of Forms of Proxy from shareholders 11.45 a.m. on 23 January 2023

General Meeting 11.45 a.m. on 25 January 2023

Results of General Meeting announced 25 January 2023

Subject to shareholder approval Marylebone Partners' appointment as investment manager will take effect from 11.59 p.m. on 25 January 2023 and its appointment as AIFM is expected to take place in Q2 2023.

Availability of the Circular

The Circular is being posted to Shareholders today.

A copy of the Circular will shortly be available to view on the Company's website at www.majedieinvestments.com. In accordance with LR 9.6.1R, a copy of the Circular has been submitted to the National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

Defined terms in the announcement have the same meaning as set out in the Circular.

 

For further information please contact:

Majedie Investments PLC +44 (0)20 7382 8185

William Barlow

J.P. Morgan Cazenove +44 (0)20 7742 4000

William Simmonds

Rupert Budge

LEI: 2138007QEY9DYONC2723

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NOGUKRKRUVUUAAA
Date   Source Headline
1st May 202410:06 amRNSTotal Voting Rights
30th Apr 20247:00 amRNSDividend Declaration
25th Apr 20245:05 pmRNSFinal Net Asset Value
25th Apr 20245:03 pmRNSMid-Month Estimated Net Asset Value
10th Apr 20245:47 pmRNSEstimated Net Asset Value
2nd Apr 202411:27 amRNSTotal Voting Rights
25th Mar 20245:17 pmRNSHolding(s) in Company
25th Mar 20245:12 pmRNSFinal Net Asset Value
25th Mar 20245:10 pmRNSMid-Month Estimated Net Asset Value
12th Mar 202410:08 amRNSDirectorate Change
11th Mar 20245:39 pmRNSEstimated Net Asset Value
1st Mar 20242:48 pmRNSTotal Voting Rights
26th Feb 20246:15 pmRNSNet Asset Value(s)
26th Feb 20246:15 pmRNSNet Asset Value(s)
22nd Feb 20245:11 pmRNSHolding(s) in Company
1st Feb 202411:11 amRNSTotal Voting Rights
31st Jan 20247:00 amRNSDividend Declaration
25th Jan 20245:52 pmRNSNet Asset Value(s)
25th Jan 20245:52 pmRNSNet Asset Value(s)
18th Jan 202412:46 pmRNSDirector Declaration
17th Jan 20244:17 pmRNSResult of AGM
10th Jan 202412:58 pmRNSNet Asset Value(s)
4th Jan 20242:30 pmRNSHolding(s) in Company
2nd Jan 20243:50 pmRNSResults analysis from Kepler Trust Intelligence
2nd Jan 202412:59 pmRNSTotal Voting Rights
22nd Dec 202312:42 pmRNSNet Asset Value(s)
22nd Dec 202312:41 pmRNSNet Asset Value(s)
18th Dec 20234:06 pmRNSBlock listing Interim Review
18th Dec 20237:00 amRNSAnnual Financial Report
11th Dec 20235:36 pmRNSNet Asset Value(s)
1st Dec 202311:47 amRNSTotal Voting Rights
27th Nov 20232:44 pmRNSNet Asset Value(s)
24th Nov 20235:19 pmRNSNet Asset Value(s)
17th Nov 20234:56 pmRNSHolding(s) in Company
10th Nov 20233:35 pmRNSNet Asset Value(s)
8th Nov 20237:05 amRNSBoard role change
8th Nov 20237:00 amRNSDividend Declaration
1st Nov 202310:42 amRNSTotal Voting Rights
25th Oct 20236:25 pmRNSNet Asset Value(s)
25th Oct 20236:25 pmRNSNet Asset Value(s)
10th Oct 20235:53 pmRNSNet Asset Value(s)
2nd Oct 202311:32 amRNSTotal Voting Rights
25th Sep 20235:14 pmRNSNet Asset Value(s)
25th Sep 20235:13 pmRNSNet Asset Value(s)
11th Sep 20235:45 pmRNSNet Asset Value(s)
1st Sep 202311:42 amRNSTotal Voting Rights
30th Aug 202312:59 pmRNSHolding(s) in Company
25th Aug 202312:59 pmRNSNet Asset Value(s)
25th Aug 202312:58 pmRNSNet Asset Value(s)
10th Aug 20236:13 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.